by aparada | Nov 23, 2020 | News FJB, News IONTAS, Press Release |
Diverse panel of novel target binders from FairJourney Biologics and IONTAS will be used to uncover functional antibodies to advance autoimmune and inflammatory disease research Porto, Portugal, Cambridge and London, UK, 23rd November 2020: FairJourney Biologics S.A...
by aparada | Oct 13, 2020 | News FJB, News IONTAS, Press Release |
IONTAS’ mammalian display technology facilitates the identification of high affinity developable full-length antibody libraries in the context of mammalian cells Cambridge, UK – 13 October 2020 – IONTAS Limited (IONTAS), an innovative biotechnology company focused on...
by aparada | Sep 28, 2020 | News FJB, Press Release |
IONTAS and FairJourney Biologics Discover SARS-CoV-2 Neutralizing Antibodies with Picomolar Potency · Panel of 15 potent antibodies selected that are optimally suited to clinical development and manufacturing · Monoclonal antibodies have the potential to both...
by aparada | Aug 10, 2020 | News FJB |
We are pleased to announce that FairJourney Biologics has been named as one of the 500 fastest-growing EMEA tech companies in the Deloitte Technology Fast 500 with FairJourney ranking 293 recognising the company’s 439 percent growth. Full list can be found...
by aparada | May 13, 2020 | News FJB |
• FairJourney’s combination with Iontas creates a leading global antibody discovery Clinical Research Organisation (‘CRO’) with an international footprint • FairJourney’s unique antibody discovery libraries and service portfolio to be complemented by Iontas’...
by aparada | Apr 16, 2020 | News FJB |
16 April 2020 • Bringing together complementary services and technology to allow faster identification of effective antibodies with a higher chance of success in development FairJourney Biologics (Porto, Portugal) and Iontas (Cambridge, UK) today announce a...
